Recurrent Retinal Detachment

Pregnant women with a history of retinal detachment were at no greater risk for recurrence after vaginal delivery compared with cesarean section, according to a study published in Retina.

The intravitreal injection of an anti-VEGF, a corticosteroid or a complement inhibitor for the treatment of potentially blinding retinal disease is today the most common procedure performed by an ophthalmologist.


NEW YORK — A focus on follow-up care and monocular precautions may help improve outcomes in pediatric patients undergoing retinal repair, according to a presenter at OSN New York Retina.

Aldeyra has enrolled the first patient in a phase 3 clinical trial of ADX-2191 for the prevention of recurrent retinal detachment due to proliferative vitreoretinopathy, according to a press release.